Szende Agota, Svensson Klas, Ståhl Elisabeth, Mészáros Agnes, Berta Gyula Y
MEDTAP International, London, UK.
Pharmacoeconomics. 2004;22(8):537-47. doi: 10.2165/00019053-200422080-00005.
To explore the relationship between asthma control level and health-related QOL (HR-QOL), and to understand the role of various psychometric and utility-based methods in studying this relationship.
Two hundred and twenty-eight consecutive adult outpatients and inpatients at four sites participated in the study. Physicians identified the level of disease control according to the Global Initiative for Asthma (GINA) classification system. Patients filled in three different HR-QOL questionnaires (EuroQol 5-D [EQ-5D], Short-Form 36-item health survey [SF-36], and St George's Respiratory Questionnaire [SGRQ]) and a direct time trade-off question. The Short Form-6D (SF-6D) was used to derive utility values from SF-36 data.
All patient-reported evaluation methods could discriminate between patients with different disease control levels, and both generic and disease-specific instruments strongly correlated to each other. The magnitude of differences in HR-QOL between groups with different disease control levels was clinically meaningful. All three HR-QOL measures reflected a relationship between disease control level and HR-QOL, but the actual pattern of the relationship depended on the instrument used. Utilities gained from the EQ-5D index, compared with the SF-6D index, had higher values in the patient group with the best disease control and lower values in the patient group with poor disease control.
When choosing an instrument to measure the health status of asthmatic patients in clinical studies, the severity range of the study population should be considered. Researchers might prefer to use the EQ-5D in asthma patients with severe disease or poor disease control and the SF-6D in patients with mild disease or good disease control.
探讨哮喘控制水平与健康相关生活质量(HR-QOL)之间的关系,并了解各种心理测量和基于效用的方法在研究这种关系中的作用。
四个地点的228名连续的成年门诊患者和住院患者参与了该研究。医生根据全球哮喘防治创议(GINA)分类系统确定疾病控制水平。患者填写了三种不同的HR-QOL问卷(欧洲五维健康量表[EQ-5D]、36项简短健康调查问卷[SF-36]和圣乔治呼吸问卷[SGRQ])以及一个直接时间权衡问题。使用简式6维健康量表(SF-6D)从SF-36数据中得出效用值。
所有患者报告的评估方法都能够区分不同疾病控制水平的患者,通用型和疾病特异性工具之间都有很强的相关性。不同疾病控制水平组之间HR-QOL的差异程度具有临床意义。所有三种HR-QOL测量方法都反映了疾病控制水平与HR-QOL之间的关系,但这种关系的实际模式取决于所使用的工具。与SF-6D指数相比,从EQ-5D指数获得的效用值在疾病控制最佳的患者组中较高,而在疾病控制较差的患者组中较低。
在临床研究中选择测量哮喘患者健康状况的工具时,应考虑研究人群的严重程度范围。研究人员可能更倾向于在患有严重疾病或疾病控制不佳的哮喘患者中使用EQ-5D,而在患有轻度疾病或疾病控制良好的患者中使用SF-6D。